0.9397 USD
-0.04 (-4.11%)
0.9792 USD
+0.04 (+4.2%)
Overall DCGO gets a fundamental rating of 3 out of 10. We evaluated DCGO against 100 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DCGO has reported negative net income.
In the past year DCGO had a positive cash flow from operations.
Of the past 5 years DCGO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of DCGO (-14.58%) is worse than 78.00% of its industry peers.
DCGO's Return On Equity of -19.07% is on the low side compared to the rest of the industry. DCGO is outperformed by 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
DCGO's Operating Margin has declined in the last couple of years.
DCGO has a Gross Margin of 31.21%. This is comparable to the rest of the industry: DCGO outperforms 60.00% of its industry peers.
DCGO's Gross Margin has been stable in the last couple of years.
DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DCGO has been reduced compared to 1 year ago.
DCGO has a worse debt/assets ratio than last year.
2.2 Solvency
DCGO has an Altman-Z score of 1.30. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.30, DCGO is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
DCGO has a debt to FCF ratio of 0.32. This is a very positive value and a sign of high solvency as it would only need 0.32 years to pay back of all of its debts.
The Debt to FCF ratio of DCGO (0.32) is better than 94.00% of its industry peers.
DCGO has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
DCGO's Debt to Equity ratio of 0.04 is amongst the best of the industry. DCGO outperforms 81.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 1.3 |
ROIC/WACCN/A
WACC8.42%
2.3 Liquidity
DCGO has a Current Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a Current ratio of 2.59. This is amongst the best in the industry. DCGO outperforms 83.00% of its industry peers.
DCGO has a Quick Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Quick ratio (2.59) than 83.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -194.14% in the last year.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.03%.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
3.2 Future
DCGO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -40.02% yearly.
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.20% yearly.
EPS Next Y-286.35%
EPS Next 2Y-75.09%
EPS Next 3Y-40.02%
EPS Next 5YN/A
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.77 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DCGO's earnings are expected to decrease with -40.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-75.09%
EPS Next 3Y-40.02%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.9397
-0.04 (-4.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.66%
Inst Owner Change-4.12%
Ins Owners7.1%
Ins Owner Change0.47%
Market Cap91.91M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.81 (199.03%)
Short Float %4.66%
Short Ratio1.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)-10.57%
PT rev (3m)-10.57%
EPS NQ rev (1m)-10.81%
EPS NQ rev (3m)-9.33%
EPS NY rev (1m)-13.1%
EPS NY rev (3m)-16.8%
Revenue NQ rev (1m)-1.69%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.25 | ||
| P/FCF | 1.77 | ||
| P/OCF | 1.59 | ||
| P/B | 0.34 | ||
| P/tB | 0.43 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)0.53
FCFY56.39%
OCF(TTM)0.59
OCFY62.89%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% | ||
| FCFM | 14.08% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.73% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 1.3 |
F-Score4
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-286.35%
EPS Next 2Y-75.09%
EPS Next 3Y-40.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.22%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
Can you provide the valuation status for DOCGO INC?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for DCGO stock?
The Earnings per Share (EPS) of DOCGO INC (DCGO) is expected to decline by -286.35% in the next year.